Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
The average daily trading volume for Recursion Pharmaceuticals (RXRX) is 62,870,086. The opening price for Recursion Pharmaceuticals today was 3.65.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results